INFevo raises over 100 million yuan in Pre-A round, a record for virtual cell startups
INFevo, a Chinese AI for Science company focused on virtual cells and recursive scientific discovery, has raised over 100 million yuan in a Pre-A round, setting a record for a single funding round by a virtual cell company. The round was backed by Xinglian Capital, Prosperity7 Ventures, Huagai Capital, Huakong Fund and DT Capital, with existing investors Shunwei Capital, Sequoia China and Songhe Capital adding more.
The money will speed up its AI4S infrastructure and connect cell response prediction, hypothesis testing and high-throughput automated lab feedback. It aims to build a full-chain AI biology platform covering target discovery, virtual screening and clinical plan optimization.
INFevo also introduced its recursive scientific discovery idea and built a two-way loop of AI foundation models and high-throughput automated experiments. Its OCOO-T model led in same-condition tests on three major single-cell perturbation benchmarks: Tahoe100M, Replogle and PBMC.
Comments
Loading comments…